FGF21 and metabolic dysfunction-associated steatotic liver disease: It has been shown that NAFLD and its progression towards fibrosis are accompanied by upregulation of pro-fibrogenic cytokines (such as fibroblast growth factor-21 and transforming growth factor-β) which might act on the kidney, as well as by a low-grade inflammation and pro-thrombotic milieu [28].